Form 4 for MRNA Moderna
Accepted 2023-05-01 00:00:00 ET · period of report 2023-04-28 · accession 0001127602-23-013922 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-01 | 2023-04-28 | MRNA | Horning Sandra | Dir | M - OptEx | — | +670 | 1,373 | +95% | — |
| D | 2023-05-01 | 2023-04-28 | MRNA | Horning Sandra | Dir | M - OptEx | $0.00 | -670 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-28 | M | A | 670 | — | 1,373 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Units | 2023-04-28 | M | D | 670 | $0.00 | 0 | D | — · — to — | 670 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) The shares subject to this restricted stock unit award vested in full on April 28, 2023. |